Bank of America
TCBPW

Bank of America’s TC BioPharm (Holdings) plc Warrants TCBPW Stock Holding History

Bank of America’s Portfolio TCBPW Stock Details TCBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-71
Closed -$1 – 8493
2024
Q3 		$1 Sell
71
-311
-81% -$5 ﹤0.01% 8138
2024
Q2 		$5 Sell
382
-200
-34% -$3 ﹤0.01% 8130
2024
Q1 		$12 Buy
582
+53
+10% +$1 ﹤0.01% 7531
2023
Q4 		$17 Buy
+529
New +$12 ﹤0.01% 7683

Other funds holding TCBPW

WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America's TCBPW Position: Q4 2024 in Review

Bank of America sold out of TC BioPharm (Holdings) plc Warrants (TCBPW) in Q4 2024, closing a stake of 71 shares — an estimated $1 sold.

Bank of America first reported a position in TCBPW in Q4 2023 and held it in 4 quarters. The position peaked at $17 in Q4 2023. 6 funds tracked by Wall St. Rank hold TCBPW as of Q4 2024.

  • Bank of America reported no remaining TC BioPharm (Holdings) plc Warrants position as of Q4 2024 after selling out during the quarter.
  • Bank of America sold 71 TC BioPharm (Holdings) plc Warrants shares in Q4 2024, an estimated $1.
  • Bank of America first reported a position in TC BioPharm (Holdings) plc Warrants in Q4 2023 and held it in 4 quarters.
  • Bank of America's TC BioPharm (Holdings) plc Warrants position peaked at $17 in Q4 2023.
  • 6 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc Warrants as of Q4 2024.

Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.